These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19942691)
1. Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004. Taori SK; Hall V; Poxton IR J Med Microbiol; 2010 Mar; 59(Pt 3):338-344. PubMed ID: 19942691 [TBL] [Abstract][Full Text] [Related]
2. The epidemiology of Clostridium difficile in Scotland. Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104 [TBL] [Abstract][Full Text] [Related]
3. Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland. Mutlu E; Wroe AJ; Sanchez-Hurtado K; Brazier JS; Poxton IR J Med Microbiol; 2007 Jul; 56(Pt 7):921-929. PubMed ID: 17577057 [TBL] [Abstract][Full Text] [Related]
5. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007]. Poilane I; Fantinato C; Cruaud P; Collignon A Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360 [TBL] [Abstract][Full Text] [Related]
6. Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009. Akerlund T; Alefjord I; Dohnhammar U; Struwe J; Noren T; Tegmark-Wisell K; Euro Surveill; 2011 Mar; 16(10):. PubMed ID: 21435322 [TBL] [Abstract][Full Text] [Related]
7. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014. Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH; Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012. Lachowicz D; Pituch H; Obuch-Woszczatyński P Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance. Pituch H; Brazier JS; Obuch-Woszczatyński P; Wultańska D; Meisel-Mikołajczyk F; Łuczak M J Med Microbiol; 2006 Feb; 55(Pt 2):207-213. PubMed ID: 16434714 [TBL] [Abstract][Full Text] [Related]
10. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Huang H; Fang H; Weintraub A; Nord CE Clin Microbiol Infect; 2009 Dec; 15(12):1170-3. PubMed ID: 19624517 [TBL] [Abstract][Full Text] [Related]
11. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008. Ilchmann C; Zaiss NH; Speicher A; Christner M; Ackermann G; Rohde H Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1571-3. PubMed ID: 20632051 [TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757 [TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. Spigaglia P; Barbanti F; Dionisi AM; Mastrantonio P J Clin Microbiol; 2010 Aug; 48(8):2892-6. PubMed ID: 20554809 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Kim J; Kang JO; Kim H; Seo MR; Choi TY; Pai H; Kuijper EJ; Sanders I; Fawley W Clin Microbiol Infect; 2013 Jun; 19(6):521-7. PubMed ID: 22712697 [TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain. Weber I; Riera E; Déniz C; Pérez JL; Oliver A; Mena A Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477 [TBL] [Abstract][Full Text] [Related]
16. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea. Kim J; Kang JO; Pai H; Choi TY Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765 [TBL] [Abstract][Full Text] [Related]
17. Sporulation properties and antimicrobial susceptibility in endemic and rare Clostridium difficile PCR ribotypes. Zidaric V; Rupnik M Anaerobe; 2016 Jun; 39():183-8. PubMed ID: 27095618 [TBL] [Abstract][Full Text] [Related]
18. The changes of PCR ribotype and antimicrobial resistance of Clostridium difficile in a tertiary care hospital over 10 years. Lee JH; Lee Y; Lee K; Riley TV; Kim H J Med Microbiol; 2014 Jun; 63(Pt 6):819-823. PubMed ID: 24696516 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic profiling of Clostridium difficile ribotype 176--A multidrug resistant relative to C. difficile ribotype 027. Krutova M; Matejkova J; Tkadlec J; Nyc O Anaerobe; 2015 Dec; 36():88-90. PubMed ID: 26256807 [TBL] [Abstract][Full Text] [Related]
20. Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal origin. Álvarez-Pérez S; Blanco JL; Harmanus C; Kuijper E; García ME Vet Microbiol; 2017 Feb; 199():15-22. PubMed ID: 28110780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]